Recombinant Human AURKB Protein，His

Aurora B Kinase (AURKB) is a crucial serine/threonine kinase that plays a pivotal role in cell division, specifically during mitosis. It is a key component of the chromosomal passenger complex, which is essential for the proper alignment and segregation of chromosomes. Dysregulation of AURKB has been linked to various cancers, making it an attractive target for therapeutic intervention. Research into AURKB recombinant protein focuses on understanding its structural and functional properties, which are vital for elucidating its role in cell cycle regulation. Recombinant AURKB can be produced through recombinant DNA technology, enabling detailed biochemical and biophysical studies. These studies aim to investigate its enzymatic activity, substrate specificity, and interactions with other mitotic proteins. By constructing mutants and analyzing their effects on cellular function, researchers can uncover the mechanisms by which AURKB contributes to oncogenesis. Furthermore, recombinant AURKB is instrumental in drug screening efforts, where small molecules or peptides can be tested for their inhibitory effects on its kinase activity. This research is not only significant for basic cell biology but also provides insights into potential therapeutic strategies for targeting AURKB in cancer treatment. As such, the exploration of AURKB recombinant protein serves as a foundational aspect of ongoing studies aimed at developing novel anti-cancer therapies and improving our understanding of mitotic regulation.